Claus Feldmann Selected Research

Glucocorticoids

11/2023	Glucocorticoid Nanoparticles Show Full Therapeutic Efficacy in a Mouse Model of Acute Lung Injury and Concomitantly Reduce Adverse Effects.
1/2020	Glucocorticoids delivered by inorganic-organic hybrid nanoparticles mitigate acute graft-versus-host disease and sustain graft-versus-leukemia activity.
10/2017	Targeted delivery of glucocorticoids to macrophages in a mouse model of multiple sclerosis using inorganic-organic hybrid nanoparticles.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Claus Feldmann Research Topics

Disease

3	Neoplasms (Cancer) 01/2024 - 03/2016
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2024 - 11/2023
2	Infections 01/2023 - 08/2018
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2024
1	Melanoma (Melanoma, Malignant) 01/2024
1	Acute Lung Injury 11/2023
1	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2023
1	Bacterial Infections (Bacterial Infection) 01/2023
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2020
1	Leukemia 01/2020
1	Inflammation (Inflammations) 01/2018
1	Multiple Sclerosis 10/2017
1	Breast Neoplasms (Breast Cancer) 03/2016
1	Body Weight (Weight, Body) 03/2016
1	Skin Neoplasms (Skin Cancer) 03/2016
1	Tuberculosis (Tuberculoses) 10/2015
1	Multiple Endocrine Neoplasia Type 2a (MEN 2) 11/2011
1	Gastroesophageal Reflux (GERD) 01/2001

Drug/Important Bio-Agent (IBA)

3	GlucocorticoidsIBA 11/2023 - 10/2017
1	Cytostatic AgentsIBA 01/2024
1	Deoxycytidine KinaseIBA 11/2023
1	Nucleoside Transport Proteins (Nucleoside Transporter)IBA 11/2023
1	Gemcitabine FDA Link 11/2023
1	Amikacin (A.M.K)FDA LinkGeneric 01/2023
1	Anti-Bacterial Agents (Antibiotics)IBA 08/2018
1	betamethasone sodium phosphate FDA LinkGeneric 01/2018
1	Fluorescent Dyes (Fluorescent Probes)IBA 01/2018
1	ZymosanIBA 01/2018
1	OvalbuminIBA 01/2018
1	Interleukin-6 (Interleukin 6)IBA 01/2018
1	BuffersIBA 03/2016
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 03/2016
1	SnWO4IBA 03/2016
1	Photosensitizing Agents (Photosensitizers)IBA 03/2016
1	Protamines (Protamine Sulfate)FDA Link 03/2016
1	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2016
1	Isoniazid (Ftivazide)FDA LinkGeneric 10/2015
1	PH.3IBA 11/2011
1	Ionic LiquidsIBA 11/2011
1	iodine monochlorideIBA 11/2011
1	P-2 (P 2)IBA 11/2011
1	OxidesIBA 01/2001
1	polyolIBA 01/2001

Therapy/Procedure

3	Therapeutics 01/2023 - 10/2015
1	Respiratory Therapy (Therapy, Respiratory) 01/2023
1	Photochemotherapy (Photodynamic Therapy) 03/2016
1	Nanospheres 10/2015